期刊文献+

卵巢上皮性癌组织和细胞中BRCA1基因的DNA甲基化程度与其mRNA和蛋白表达的关系

原文传递
导出
摘要 文献报道,90%的家族性卵巢上皮性癌(家庭性卵巢癌,指有家族史的卵巢癌患者)与BRCA1基因突变有关,而BRCA1基因突变仅发生在极少的散发性卵巢癌(指患者的一级和二级亲属中未发现卵巢癌患者)中,但无论是在家族性还是散发性卵巢癌中,约90%的患者其癌组织中的BRCA1 mRNA和蛋白表达水平下降。除基因突变外,引起肿瘤抑制基因失活的另一个机制就是DNA甲基化。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2007年第8期557-559,共3页 Chinese Journal of Obstetrics and Gynecology
基金 湖北省科技攻关课题(2005AA304B09)
  • 相关文献

参考文献8

  • 1Karlan B, Boyd J, Strong L, et al. Discussion: hereditary ovarian cancer. Gynecol Oncol, 2003, 88: 11-13.
  • 2Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Nail Cancer Inst, 2000, 92: 564-569.
  • 3Baylin SB, Herman JG, Graft JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998, 72 : 141-196.
  • 4Baldwin RL, Nemeth E, Tran H, et al. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res, 2000, 60:5329-5333.
  • 5Berchuck A, Heron KA, Carney ME, et al. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res, 1998, 4:2433-2437.
  • 6Blagosklonny MV, An WG, MeliUo G, et aL Regulation of BRCA1 by protein degradation. Oncogene, 1999, 18:6460-6468.
  • 7Rathi A, Virmani AK, Schorge JO, et al. Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clin Cancer Res, 2002, 8:3324-3331.
  • 8Imura M, Yamashita S, Cai LY, et al. Methylation and expression analysis of 15 genes and three nonnally-methylated genes in 13 ovarian cancer cell lines. Cancer Lett, 2006, 241 ;213-220.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部